Hansa Biopharma — November 2021
-
Hansa Biopharma to initiate Phase 3 study of imlifidase to treat anti-Glomerular Basement Membrane (anti-GBM) disease after successful pre-IND meeting with U.S. FDA
(11/15/2021)
-
"Den nu avslutade fas 2-studien visade att två tredjedelar av patienterna inte behövde dialys sex månader efter behandling med imlifidase. Detta positiva resultat validerar imlifidase som en potentiell behandling av allvarliga IGG-medierade autoimmuna sjukdomar, skriver Hansa Biopharma."
Super!
-
Er MSE ved at lukke deres shorts? De har også bombet kursen langt ned over lang tid, og begynder måske at lukke nogle shorts. Lad os se, de giver nok ikke så let op.
-
Så shorter MSE igen....møgirriterende som de bomber Hansa.
-
Hansa Biopharma; FDA opens the door for the next pivotal Phase 3 study
-
Uddrag:
"In our view, Hansa Biopharma’s ability to progress the progress of the anti-GBM opportunity for the imlifidase platform is distinctly positive. This follows a successful pre-IND meeting with the FDA. Recently we have seen several FDA delays in this sector, and Hansa’s ability to timely progress this candidate to the third pivotal Phase 3 trial is an achievement."
-
Vælg: Blankningspositioner i Hansa Biopharma AB
Blankningsregister.se
Ett register över blankningspositioner i noterade bolag. Här publiceras korta positioner från 0,2% och uppåt.
(www.blankningsregister.se)
-
Hansa Biopharma to start Phase III anti-GBM disease therapy trial
Hansa Biopharma to start Phase III anti-GBM disease therapy trial
Hansa has decided to begin the Phase III trial of imlifidase for the treatment of anti-Glomerular Basement Membrane (anti-GBM) disease.
Clinical Trials Arena (www.clinicaltrialsarena.com)
(Clinicaltrialsarena)
-
Hvad kunne være en realistisk kurstrigger, som kunne give shorterne i Hansa lidt tynd mave?
-
Er nogle af dem realistiske på den korte bane? Godt nok mange shorts, så de må jo være rimelig sikre på deres shorts lige nu?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind